Xeno Laboratories Test Blends Multi Ester Injectable Line
Out of stock
Injection · 100 mg/ml · 10 ml
Xeno Laboratories Primobolan is methenolone enanthate at 100 mg/ml in a multi-dose vial, a mild DHT-derived injectable androgen that does not aromatise and is studied for clean, gradual change rather than fast size.
GMP-manufactured and HPLC-verified, with a Certificate of Analysis per batch, shipped internationally and to the United States with dispatch within two business days.
Xeno Laboratories Primobolan is methenolone enanthate at 100 mg/ml in a multi-dose vial for intramuscular injection. Methenolone has a moderate anabolic and weak androgenic profile, which places it among the gentlest injectable androgens in this line, and it does not aromatise, so no estradiol-linked water retention is expected from it. It is normally discussed next to a base ester such as Xeno Laboratories Testosterone, because the compound itself supplies no estrogen and no rapid size.
The molecule is a 5-alpha reduced androgen, so the ring system cannot be converted to estradiol by aromatase, and the hepatic risk described for 17-alpha-alkylated orals is not reported for this ester. The enanthate chain is the reason the compound moves slowly: published profiles put the elimination half-life at about 10.5 days after intramuscular injection, which is the longest in the methenolone ester group and means levels build and fall over weeks rather than days. Like every injected androgen it suppresses natural testosterone production.
Methenolone was a registered medicine for anaemia in some markets and was withdrawn in most of them, so there is no sports dosing schedule to quote. Community figures run from about 200 to 300 mg per week at the low end to 600 mg per week at the top, spread over 10 to 16 weeks, usually with a testosterone base. Recovery is planned rather than improvised, and a SERM such as Clomid is part of that discussion. Nothing here is a prescription or a dosing guide.
For laboratory research only. Not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a healthcare professional before use.
| Trade Name | Primobolan |
| Generic Name | Methenolone enanthate |
| Manufacturer | Xeno Laboratories |
| Dosage | 100 mg/ml |
| Package | Multi-dose vial |
| Drug Class | Injectable anabolic androgenic steroid |
| Administration | Intramuscular injection |
| Storage | Room temperature, away from light and heat |
| Prescription Status | Controlled anabolic steroid, not a registered medicine |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | International and U.S. domestic options |
For laboratory research only. Consult a healthcare professional before use. Amounts shown are research references, not recommended human doses.
Before you ask
Primobolan is the trade name of methenolone. This vial carries the injectable enanthate ester at 100 mg/ml, not the oral acetate. Methenolone is a 5-alpha reduced androgen with a moderate anabolic and weak androgenic profile, so it is one of the mildest injectables in the line, and it was a registered medicine for anaemia before being withdrawn in most markets.
No. Methenolone is not converted to estradiol by aromatase, so the compound itself brings no water retention and no breast tenderness, and a mild appearance rather than a bloated one is expected. As with any non-aromatising androgen, this can leave estrogen low once a strong base ester is out of the picture, which is exactly why these vials are usually read beside a testosterone base and beside bloodwork.
The published elimination half-life is about 10.5 days after intramuscular injection, the longest of the methenolone esters, which is why twice-weekly reference injections are enough. Urine metabolites are described as clearing over weeks rather than days, and newer long-term metabolites extend that window. No single agreed week figure was found, so the exact detection window stays unconfirmed.
Because the androgenic rating is low, acne and hair shedding are reported less often than with stronger DHT compounds, but they are not absent. The predictable effect of any injected androgen is suppression of natural testosterone production, so recovery has to be planned. Hepatotoxicity is not described for this ester, and the changes seen in routine bloodwork are the usual lipid shift and a fall in endogenous testosterone.
With no registered sports use there is no approved dose to quote. Community references sit at roughly 200 to 300 mg per week for a first block, 400 to 500 mg at the intermediate level and 600 mg at the top, run for 10 to 16 weeks, injections split twice weekly because of the long ester. These are community protocols for discussion, not a recommendation, and the compound is widely described as slow to show anything.
This vial is listed as research material with international checkout and a U.S. domestic option. It is shipped from stock, orders are handled within one to two business days, and each batch ships with an HPLC report. Stock, variant and the current price are shown in the product block above; at the time of checking, the listing carried an out of stock marker while packs are restocked, so confirm the stock line before ordering.
Be the first to share your experience with Xeno Laboratories Primobolan Enanthate 100 mg Research Vial
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock